Purchase Order 36C26124P0089
Award Date 10/5/23
Potential Completion Date 10/31/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company based in Memphis, Tennessee. The contract is for the delivery of the specialty medication treprostinil 53 mcg capsules, inhalation, to support the healthcare needs of veterans served by the VA's Veterans Integrated Service Network 2 (VISN 2). The contract has a total ceiling value of $17,490.24 and a period of...
- This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
- The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical drug Uptravi-Selexipag. The $144,743.29 contract has a completion date of March 17, 2022 and supports the VHA's distribution of critical medications to treat pulmonary arterial hypertension for patients and...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set aside designation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The order is for the delivery of UPTRAVI to locations in Palo Alto, California, with a potential value of $13,985.29 and an completion date of April 20, 2023. As a prime contractor, Accredo Health Group will utilize its specialty pharmacy services and distribution network to directly...
- This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
- This is a federal contract award to Accredo Health Group, Inc., a prime contractor, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21. The award is for the specialty medication UPTRAVI, with a potential value of $104,778.03 and a completion date of September 30, 2021. The contract is a firm fixed price purchase order with no set-aside designation. Accredo Health Group, a for-profit organization, provides specialty pharmacy...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VHA VISN 6) awarded a $184,877.16 firm fixed price purchase order to Accredo Health Group, Inc. to deliver TYVASCO 0.6 MG REFILL medication. The contract has a period of performance through January 31, 2024. No set-aside designation was used for this award to the prime contractor Accredo Health Group, Inc. located in Bartlett, Tennessee. The VHA VISN 6 oversees healthcare services for...
- This is a federal purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a specialty pharmacy services provider, for the supply of TYVASCO MEDICATION 0.6MG REFILL KITS. The $14,693.72 firm fixed-price contract has an ultimate completion date of October 9, 2024. Accredo, a subsidiary of Express Scripts, is a prime contractor that specializes in distributing complex and costly drugs used to treat chronic conditions, particularly in support of the VA's...
- This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...